---
title: "Ozagrel - Vasospasm, Intracranial"
sidebar: mydoc_sidebar
permalink: db12017-mesh-d020301-1.html
toc: false 
---


Path ID: `DB12017_MESH_D020301_1`
{% include image.html url="images/db12017-mesh-d020301-1.png" file="db12017-mesh-d020301-1.png" alt="db12017-mesh-d020301-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C034364">MESH:C034364 </a> | ozagrel | Drug |
| <a href="https://identifiers.org/UniProt:P24557">UniProt:P24557 </a> | Thromboxane-A synthase | Protein |
| <a href="https://identifiers.org/MESH:D013928">MESH:D013928 </a> | Thromboxane A2 | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D020301">MESH:D020301 </a> | Vasospasm, Intracranial | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ozagrel | DECREASES ACTIVITY OF | Thromboxane-A Synthase |
| Thromboxane-A Synthase | INCREASES ABUNDANCE OF | Thromboxane A2 |
| Thromboxane A2 | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Vasospasm, Intracranial |
|---------|-----------|---------|

Comment: Ozagrel is in phase III trial.

Reference: 
  - [https://go.drugbank.com/drugs/DB12017#mechanism-of-action](https://go.drugbank.com/drugs/DB12017#mechanism-of-action)
  - [https://drugs.ncats.io/substances?q=%22OZAGREL%22](https://drugs.ncats.io/substances?q=%22OZAGREL%22)
  - [https://www.uniprot.org/uniprot/P24557#function](https://www.uniprot.org/uniprot/P24557#function)
  - [https://en.wikipedia.org/wiki/Cerebral_vasospasm](https://en.wikipedia.org/wiki/Cerebral_vasospasm)
